Atlas Trials

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

Clinical trial NCT05052502 · COMPLETED

Trial details

NCT number
NCT05052502
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Plasmodium Falciparum MalariaPlasmodium Vivax Malaria
Start date
2020-11-01
Primary completion
2022-03-31
Enrollment
14977

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.